Neonc Technologies Holdings, Inc.
NASDAQ:NTHIBiotechnology
Healthcare
$4.16 +2.94%
+$0.14 today
- Market cap
- $120.02M
- Beta
- 0.29
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$1.66
52W Low $3.20High $12.99
Volume 0.27M
Average 0.08M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$20.36M
FY 2025 · Annual
Investing Cash Flow
-$500,000.00
FY 2025 · Annual
Financing Cash Flow
$20.86M
FY 2025 · Annual
Cash Flow Statement
USD
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$62.1M
+ D&A$36.5K
+ Stock-Based Comp$35.6M
+ Deferred Tax$0
+ Working Capital$2.1M
+ Other Non-Cash$4.1M
= Operating Cash Flow-$20.4M
- Capex-$500.0K
= Free Cash Flow-$20.9M
Analysis
FY2025 free cash flow is -$20.9M. FCF conversion is 33.6% of net income. Operating cash flow was -$20.4M, with capex of -$500.0K. The largest bridge item is Stock-Based Comp at $35.6M.
Competitors
Peer companies in the same sector
No competitor data available.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 9, 2026 |
Does NTHI generate free cash flow?
Neonc Technologies Holdings, Inc. (NTHI) generated -$20.86M of free cash flow in fiscal 2025.
How much operating cash flow does NTHI produce?
Operating cash flow was -$20.36M, before capital expenditures of $500,000.00.
Continue the stock analysis
Jump to another research area for this company.